1. Home
  2. ALCO vs GBIO Comparison

ALCO vs GBIO Comparison

Compare ALCO & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALCO
  • GBIO
  • Stock Information
  • Founded
  • ALCO 1960
  • GBIO 2016
  • Country
  • ALCO United States
  • GBIO United States
  • Employees
  • ALCO N/A
  • GBIO N/A
  • Industry
  • ALCO
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALCO
  • GBIO Health Care
  • Exchange
  • ALCO Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • ALCO 198.4M
  • GBIO 165.5M
  • IPO Year
  • ALCO N/A
  • GBIO 2020
  • Fundamental
  • Price
  • ALCO $26.75
  • GBIO $2.31
  • Analyst Decision
  • ALCO
  • GBIO Buy
  • Analyst Count
  • ALCO 0
  • GBIO 4
  • Target Price
  • ALCO N/A
  • GBIO $7.50
  • AVG Volume (30 Days)
  • ALCO 31.0K
  • GBIO 114.1K
  • Earning Date
  • ALCO 12-04-2024
  • GBIO 11-07-2024
  • Dividend Yield
  • ALCO 0.74%
  • GBIO N/A
  • EPS Growth
  • ALCO N/A
  • GBIO N/A
  • EPS
  • ALCO 3.41
  • GBIO N/A
  • Revenue
  • ALCO $46,388,000.00
  • GBIO $13,174,000.00
  • Revenue This Year
  • ALCO $28.76
  • GBIO $99.36
  • Revenue Next Year
  • ALCO $73.96
  • GBIO N/A
  • P/E Ratio
  • ALCO $7.73
  • GBIO N/A
  • Revenue Growth
  • ALCO 15.40
  • GBIO 1397.05
  • 52 Week Low
  • ALCO $23.55
  • GBIO $0.86
  • 52 Week High
  • ALCO $31.00
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • ALCO 47.30
  • GBIO 44.91
  • Support Level
  • ALCO $24.87
  • GBIO $2.28
  • Resistance Level
  • ALCO $26.57
  • GBIO $2.54
  • Average True Range (ATR)
  • ALCO 0.93
  • GBIO 0.20
  • MACD
  • ALCO -0.02
  • GBIO 0.00
  • Stochastic Oscillator
  • ALCO 55.29
  • GBIO 14.00

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: